The management of mineral and bone metabolism in individuals with CKD includes vitamin D replacement, oral supplementation of calcium, and, in more advanced disease, the administration of intestinal phosphate binders.36 These measures aim to increase the intestinal absorption of calcium, address hypocalcemia, prevent hyperphosphatemia, and manage the progressive increase of parathyroid hormone levels. Here, PTH is linked to chronic kidney disease.